APEXCELLA

Immunostimulants; Cells for medical use; Biological tissue cultures for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical agents for treating aging, oncology and autoimmune disease; Antivirals; Biocides; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment; Blood for medical purposes; Adjuvants for medical purposes; Pharmaceuticals, namely, immunotherapy being immunostimulators; Pharmaceutical products for the prevention and treatment of cancer; Stem cells for medical purposes; Reagents for medical use; Diagnostic reagents for medical use

Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Research and development in the field of cancer immunotherapy; Research and development of new products for others; Technological research in the field of cancer immunotherapy; Conducting of feasibility studies in the field of new technologies; Technical writing for others; Scientific laboratory services; Scientific research; Technological consultancy services in the field of cancer immunotherapy; Scientific and technological research relating to cancer immunotherapy; Culturing of cells for others for scientific research purposes; New product design services; Custom design of prototypes; Quality control of goods and services; Product quality testing services